|Articles|March 1, 2006
- Pharmaceutical Executive-03-01-2006
- Volume 0
- Issue 0
South Africa
Author(s)Frederic Boucheseiche, Kirsten Craze
Sponsored and produced by Focus Reports.
Advertisement
Articles in this issue
almost 20 years ago
Global Report: Chemicals Legislation in Europealmost 20 years ago
Pharma's Next Top Model: Slimmer Business Modelsalmost 20 years ago
Market Research Roundtablealmost 20 years ago
Holding Their Breath: Inhaled Insulinalmost 20 years ago
Sales Management: Spending Under Scrutinyalmost 20 years ago
Genzyme: The Price of Successalmost 20 years ago
Invisible Prescribers: What You Do and Don't Know About NPs and PAsalmost 20 years ago
From the Editor: Fine Whinesalmost 20 years ago
Legal: Hey, Good Lookin': Sex Discrimination in Hiring Repsalmost 20 years ago
Thought Leader: Q&A with Hugo StephensonNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
5
